Skip to content
10-Q

Quarterly Report

NEXIMMUNE, INC.

0001538210-24-000008

← back to feed
Filed
May 20, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 15, 2024 1.37M sh
Shares Diluted Q1 2024 · Mar 31, 2024 1.25M sh
Shares Diluted restated Q1 2024 · Mar 31, 2023 1.04M sh
Capex Q1 2024 · Mar 31, 2024 $0
Capex Q1 2024 · Mar 31, 2023 $42.72K
Operating Cash Flow Q1 2024 · Mar 31, 2024 −$2.42M
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$12.28M
Cash And Equivalents Q1 2024 · Mar 31, 2024 $4.45M
Cash And Equivalents Q1 2024 · Dec 31, 2023 $3.2M
Stockholders Equity Q1 2024 · Mar 31, 2024 $2.74M
Stockholders Equity Q1 2024 · Dec 31, 2023 $3.51M
Stockholders Equity Q1 2024 · Mar 31, 2023 $23.58M
Stockholders Equity Q1 2024 · Dec 31, 2022 $32.3M
Current Liabilities Q1 2024 · Mar 31, 2024 $4.63M
Current Liabilities Q1 2024 · Dec 31, 2023 $5.08M
Total Liabilities Q1 2024 · Mar 31, 2024 $6.02M
Total Liabilities Q1 2024 · Dec 31, 2023 $5.08M
Current Assets Q1 2024 · Mar 31, 2024 $6.04M
Current Assets Q1 2024 · Dec 31, 2023 $5.4M
Total Assets Q1 2024 · Mar 31, 2024 $8.99M
Total Assets Q1 2024 · Dec 31, 2023 $8.59M
Eps Diluted Q1 2024 · Mar 31, 2024 −$2.46
Eps Diluted restated Q1 2024 · Mar 31, 2023 −$9.17
Eps Basic Q1 2024 · Mar 31, 2024 −$2.46
Eps Basic restated Q1 2024 · Mar 31, 2023 −$9.17
Sga Expense Q1 2024 · Mar 31, 2024 $2.01M
Sga Expense Q1 2024 · Mar 31, 2023 $3.7M
Rd Expense Q1 2024 · Mar 31, 2024 $744.02K
Rd Expense Q1 2024 · Mar 31, 2023 $6.12M
Net Income Q1 2024 · Mar 31, 2024 −$3.08M
Net Income Q1 2024 · Mar 31, 2023 −$9.57M
Operating Income Q1 2024 · Mar 31, 2024 −$2.76M
Operating Income Q1 2024 · Mar 31, 2023 −$9.83M